WO2016184160A1 - 手性螺环膦-氮-硫三齿配体及其制备方法和应用 - Google Patents
手性螺环膦-氮-硫三齿配体及其制备方法和应用 Download PDFInfo
- Publication number
- WO2016184160A1 WO2016184160A1 PCT/CN2016/072087 CN2016072087W WO2016184160A1 WO 2016184160 A1 WO2016184160 A1 WO 2016184160A1 CN 2016072087 W CN2016072087 W CN 2016072087W WO 2016184160 A1 WO2016184160 A1 WO 2016184160A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formula
- group
- chiral
- nitrogen
- compound
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title claims abstract description 61
- 125000003003 spiro group Chemical group 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- BFZUFHPKKNHSAG-UHFFFAOYSA-N [N].[P].[S] Chemical compound [N].[P].[S] BFZUFHPKKNHSAG-UHFFFAOYSA-N 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 43
- FBVGKIOCASRSER-UHFFFAOYSA-N P.[S].[N] Chemical compound P.[S].[N] FBVGKIOCASRSER-UHFFFAOYSA-N 0.000 claims abstract description 30
- 150000001728 carbonyl compounds Chemical class 0.000 claims abstract description 20
- 239000003054 catalyst Substances 0.000 claims abstract description 19
- 238000009903 catalytic hydrogenation reaction Methods 0.000 claims abstract description 18
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- 229910052723 transition metal Inorganic materials 0.000 claims abstract description 9
- 239000007858 starting material Substances 0.000 claims abstract description 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract 2
- 238000006243 chemical reaction Methods 0.000 claims description 41
- -1 lithium aluminum hydride Chemical group 0.000 claims description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 18
- 239000003153 chemical reaction reagent Substances 0.000 claims description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims description 16
- 239000007787 solid Substances 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 125000001072 heteroaryl group Chemical group 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 14
- 239000003960 organic solvent Substances 0.000 claims description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 13
- 239000001257 hydrogen Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 125000001424 substituent group Chemical group 0.000 claims description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 10
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000002585 base Substances 0.000 claims description 9
- 239000011593 sulfur Substances 0.000 claims description 9
- 229910052717 sulfur Inorganic materials 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 150000002430 hydrocarbons Chemical group 0.000 claims description 8
- PSCMQHVBLHHWTO-UHFFFAOYSA-K indium(iii) chloride Chemical compound Cl[In](Cl)Cl PSCMQHVBLHHWTO-UHFFFAOYSA-K 0.000 claims description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 8
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims description 6
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 claims description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 6
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 6
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 239000012298 atmosphere Substances 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 6
- 125000002541 furyl group Chemical group 0.000 claims description 6
- 125000004076 pyridyl group Chemical group 0.000 claims description 6
- 229910052707 ruthenium Inorganic materials 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 125000001544 thienyl group Chemical group 0.000 claims description 6
- 150000004798 β-ketoamides Chemical class 0.000 claims description 6
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 5
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 claims description 5
- OGFKTAMJLKHRAZ-UHFFFAOYSA-N 2,2-dimethoxyacetaldehyde Chemical compound COC(OC)C=O OGFKTAMJLKHRAZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000002841 Lewis acid Substances 0.000 claims description 5
- 150000002576 ketones Chemical class 0.000 claims description 5
- 150000007517 lewis acids Chemical class 0.000 claims description 5
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 4
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 238000005984 hydrogenation reaction Methods 0.000 claims description 4
- 150000007529 inorganic bases Chemical class 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 150000007530 organic bases Chemical class 0.000 claims description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 230000002829 reductive effect Effects 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 claims description 4
- 238000001308 synthesis method Methods 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- 150000003573 thiols Chemical class 0.000 claims description 4
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 3
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- RRKODOZNUZCUBN-CCAGOZQPSA-N (1z,3z)-cycloocta-1,3-diene Chemical compound C1CC\C=C/C=C\C1 RRKODOZNUZCUBN-CCAGOZQPSA-N 0.000 claims description 2
- 229910015900 BF3 Inorganic materials 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- 229910018286 SbF 6 Inorganic materials 0.000 claims description 2
- GJEAMHAFPYZYDE-UHFFFAOYSA-N [C].[S] Chemical group [C].[S] GJEAMHAFPYZYDE-UHFFFAOYSA-N 0.000 claims description 2
- PFRUBEOIWWEFOL-UHFFFAOYSA-N [N].[S] Chemical compound [N].[S] PFRUBEOIWWEFOL-UHFFFAOYSA-N 0.000 claims description 2
- 239000007825 activation reagent Substances 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 claims description 2
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical group CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 claims description 2
- 125000002883 imidazolyl group Chemical group 0.000 claims description 2
- LZWQNOHZMQIFBX-UHFFFAOYSA-N lithium;2-methylpropan-2-olate Chemical compound [Li+].CC(C)(C)[O-] LZWQNOHZMQIFBX-UHFFFAOYSA-N 0.000 claims description 2
- ULWOJODHECIZAU-UHFFFAOYSA-N n,n-diethylpropan-2-amine Chemical compound CCN(CC)C(C)C ULWOJODHECIZAU-UHFFFAOYSA-N 0.000 claims description 2
- 239000001301 oxygen Chemical group 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 claims description 2
- 238000006268 reductive amination reaction Methods 0.000 claims description 2
- 229910052703 rhodium Inorganic materials 0.000 claims description 2
- 239000010948 rhodium Substances 0.000 claims description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 2
- CGFYHILWFSGVJS-UHFFFAOYSA-N silicic acid;trioxotungsten Chemical compound O[Si](O)(O)O.O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1.O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1.O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1.O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1 CGFYHILWFSGVJS-UHFFFAOYSA-N 0.000 claims description 2
- 239000012279 sodium borohydride Substances 0.000 claims description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000012321 sodium triacetoxyborohydride Substances 0.000 claims description 2
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- DUNKXUFBGCUVQW-UHFFFAOYSA-J zirconium tetrachloride Chemical compound Cl[Zr](Cl)(Cl)Cl DUNKXUFBGCUVQW-UHFFFAOYSA-J 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 claims 5
- 239000002253 acid Substances 0.000 claims 2
- 239000012018 catalyst precursor Substances 0.000 claims 2
- 238000006073 displacement reaction Methods 0.000 claims 2
- FOJXVQNESDUSMB-UHFFFAOYSA-N C(=O)OC(C)C.[Cl] Chemical compound C(=O)OC(C)C.[Cl] FOJXVQNESDUSMB-UHFFFAOYSA-N 0.000 claims 1
- XQJHRCVXRAJIDY-UHFFFAOYSA-N aminophosphine Chemical compound PN XQJHRCVXRAJIDY-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims 1
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 abstract description 5
- 230000003197 catalytic effect Effects 0.000 abstract description 4
- 230000003287 optical effect Effects 0.000 abstract description 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N benzocyclopentane Natural products C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 abstract 1
- 229910052741 iridium Inorganic materials 0.000 abstract 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 abstract 1
- 125000004149 thio group Chemical group *S* 0.000 abstract 1
- 238000005481 NMR spectroscopy Methods 0.000 description 52
- 238000003786 synthesis reaction Methods 0.000 description 20
- 230000015572 biosynthetic process Effects 0.000 description 19
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000012043 crude product Substances 0.000 description 6
- 239000002274 desiccant Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000000967 suction filtration Methods 0.000 description 6
- 238000006555 catalytic reaction Methods 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 0 *c1c([C@@](CC2)(CCc3ccc4)c3c4N)c2ccc1 Chemical compound *c1c([C@@](CC2)(CCc3ccc4)c3c4N)c2ccc1 0.000 description 3
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
- 238000009905 homogeneous catalytic hydrogenation reaction Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- ZJLMKPKYJBQJNH-UHFFFAOYSA-N propane-1,3-dithiol Chemical compound SCCCS ZJLMKPKYJBQJNH-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 125000000101 thioether group Chemical group 0.000 description 2
- UJXIOVIFPTXDHU-UHFFFAOYSA-N 2-phenylethanethioyl chloride Chemical compound ClC(=S)CC1=CC=CC=C1 UJXIOVIFPTXDHU-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 241000819038 Chichester Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 241000761456 Nops Species 0.000 description 1
- 239000012327 Ruthenium complex Substances 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000004807 desolvation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- PDPJQWYGJJBYLF-UHFFFAOYSA-J hafnium tetrachloride Chemical compound Cl[Hf](Cl)(Cl)Cl PDPJQWYGJJBYLF-UHFFFAOYSA-J 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/5022—Aromatic phosphines (P-C aromatic linkage)
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
- B01J31/189—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms containing both nitrogen and phosphorus as complexing atoms, including e.g. phosphino moieties, in one at least bidentate or bridging ligand
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2204—Organic complexes the ligands containing oxygen or sulfur as complexing atoms
- B01J31/226—Sulfur, e.g. thiocarbamates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J37/00—Processes, in general, for preparing catalysts; Processes, in general, for activation of catalysts
- B01J37/04—Mixing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B53/00—Asymmetric syntheses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/16—Preparation of optical isomers
- C07C231/18—Preparation of optical isomers by stereospecific synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
- C07C29/145—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones with hydrogen or hydrogen-containing gases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
- C07C29/149—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof with hydrogen or hydrogen-containing gases
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0033—Iridium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/505—Preparation; Separation; Purification; Stabilisation
- C07F9/5054—Preparation; Separation; Purification; Stabilisation by a process in which the phosphorus atom is not involved
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655363—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/60—Reduction reactions, e.g. hydrogenation
- B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
- B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
- B01J2231/643—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of R2C=O or R2C=NR (R= C, H)
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
- B01J2531/0238—Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
- B01J2531/0241—Rigid ligands, e.g. extended sp2-carbon frameworks or geminal di- or trisubstitution
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/827—Iridium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2442—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring comprising condensed ring systems
- B01J31/249—Spiro-condensed ring systems
Definitions
- the invention relates to a chiral spiro phosphine-nitrogen-sulfur tridentate ligand, preparation method and application thereof, and particularly to a method for preparing chiral spiro phosphine-nitrogen-sulfur tridentate ligand with spiro ring skeleton And in the application of asymmetric catalytic hydrogenation of carbonyl compounds, belonging to the field of organic synthesis technology.
- asymmetric reaction catalyzed by chiral transition metal complexes is the most effective method for obtaining optically active chiral compounds, and has been widely used in industrial production of chiral drugs.
- chiral ligands and their catalysts are the key to the efficient and highly enantioselective synthesis of chiral compounds. For this reason, in the past few decades of research, the development of new high-efficiency, highly selective chiral ligands and their catalysts has been receiving attention.
- ruthenium complex Ir-SpiroPAP has outstanding performance in the asymmetric catalytic hydrogenation of carbonyl compounds with an enantioselectivity of up to 99% ee and a TON of up to 4.5 million.
- the chiral spiropyridylaminophosphine tridentate ligand ruthenium catalyst Ir-SpiroPAP is also very effective for the asymmetric catalytic hydrogenation of ⁇ -ketoesters, except that it gives an enantioselectivity of up to 99% ee. Up to 1.23 million (Xie, J.-H.; Liu, X.-Y.; Yang, X.-H.; Xie, J.-B.; Wang, L.-X.; Zhou, Q.-L) .Angew. Chem. Int. Ed. 2012, 51, 201-203).
- the chiral spirocyclic ruthenium catalyst Ir-SpiroPAP gives only high enantioselectivity for ⁇ -aryl- ⁇ -ketoesters and only moderately for ⁇ -alkyl- ⁇ -ketoesters. Enantioselectivity ( ⁇ 60% ee).
- the catalyst for the efficient asymmetric catalytic hydrogenation of ⁇ -alkyl- ⁇ -ketoester is limited to the ruthenium halide catalyst of chiral bisphosphine ligand, but most of the catalysts TON does not exceed 10,000, and it is often necessary to add an additive such as hydrochloric acid which is corrosive to the metal reaction vessel (Ohkuma, T.; Noyori, R. in Handbook of Homogeneous Hydrogenation, Eds.: de Vries, JG; Elsevier, CJ, Wiley -VCH, Weinheim, 2007, pp. 1105).
- the object of the present invention is to provide a kind of chiral spiro phosphine-nitrogen-sulfur tridentate ligand and a preparation method and application thereof.
- the chiral spirotrident tridentate ligand is based on chiral spiropyridinium phosphine tridentate
- the structure of the ligand ruthenium catalyst Ir-SpiroPAP is designed in the asymmetric catalytic hydrogenation of carbonyl compounds with the catalytic activity and enantioselectivity.
- the chiral spiro phosphine-nitrogen-sulfur tridentate ligand provided by the present invention is a compound having the formula I or formula II or an enantiomer, a racemate, or a catalytically acceptable salt thereof.
- R 1 is selected from a C 1 -C 10 hydrocarbon group, a phenyl group, a substituted phenyl group, a 1-naphthyl group, a 2-naphthyl group, a heteroaryl group or a benzyl group, and the substituent on the phenyl group is C 1 a hydrocarbon group or alkoxy group of -C 10 , the number of substituents is 1 to 5, and the heteroaryl group is a furyl group, a thienyl group or a pyridyl group;
- R 2 , R 3 , R 4 and R 5 are each independently selected from H, C1-C10 alkyl, phenyl, substituted phenyl, 1-naphthyl, 2-naphthyl, heteroaryl or benzyl, said The substituent on the phenyl group is a C 1 -C 10 hydrocarbon group, an alkoxy group, the number of substituents is 1 to 5, the heteroaryl group is a furyl group, a thienyl group or a pyridyl group; or a C1 to C10 alkoxy group; or R 2 to R 3 and R 4 to R 5 are a C3 to C7 aliphatic ring or an aromatic ring; and R 2 , R 3 , R 4 and R 5 may be the same or different;
- R 8 and R 9 are each independently selected from a C1 to C10 alkyl group, a C1 to C10 alkoxy group, a phenyl group, a substituted phenyl group, a 1-naphthyl group, a 2-naphthyl group, a heteroaryl group or a benzyl group, and the benzene is benzene.
- the substituent on the group is a C 1 -C 10 hydrocarbon group, an alkoxy group, the number of substituents is 1 to 5, the heteroaryl group is a furyl group, a thienyl group or a pyridyl group; or R 8 and R 9 may pass C 2 to C 4
- the carbon chain, nitrogen, oxygen, sulfur carbon chain, aromatic ring, or heteroaromatic ring is connected to form a ring; R 8 and R 9 may be the same or different.
- the preparation method of the chiral spirophosphine-nitrogen-sulfur tridentate ligand provided by the invention is characterized in that the racemic or optically active 7-diaryl group represented by formula 1 having a chiral spiroindoline skeleton is Alkylphosphino-7'-amino-1,1'-spirobihydroindoles are prepared as starting materials by the following reaction formula:
- R 1 to R 9 in the formulas 1, 2, 3, and 4 are the same as the above, wherein X in the formula 2 is H, Cl, Br, or an imidazolyl group, or OH; a formula having a chiral spiroindoline skeleton
- X in the formula 2 is H, Cl, Br, or an imidazolyl group, or OH
- a formula having a chiral spiroindoline skeleton The compound shown in 1 was prepared by literature method (Jian-Bo Xie, Jian-Hua Xie, Xiao-Yan Liu, Wei-Ling Kong, Shen Li, Qi-Lin Zhou, J. Am. Chem. Soc. 2010, 132). , 4538; Zhou Qilin, Xie Jianhua, Xie Jianbo, Wang Lixin, CN 101671365A).
- the preparation method of the chiral spirophosphine-nitrogen-sulfur tridentate ligand is described as follows: in the presence of an organic solvent and a base, the compound represented by Formula 1 is first compounded with Formula 2 (X is not H and OH) in the reaction The compound shown in Formula 3 is prepared by reacting in the apparatus for 2 to 24 hours; the compound represented by Formula 3 is subsequently reduced by a reducing reagent to obtain a chiral spirophosphine-nitrogen-sulfur tridentate ligand represented by Formula I; or in organic The compound of the formula 1 is reacted with the compound of the formula 2 (X is H) in the presence of a solvent and a reducing reagent, and is directly reacted in a reactor for 2 to 24 hours to obtain a chiral spiro phosphine represented by the formula I.
- the compound of the formula 1 is first reacted with the compound of the formula 2 (X is OH) in a reactor for 2 to 24 hours to obtain the formula 3
- the compound of Formula 3 is subsequently reduced with a reducing reagent to give a chiral spiro phosphine-nitrogen-sulfur tridentate ligand of Formula I; the compound of Formula 1 and the compound of Formula 2 ( X is OH) and the molar ratio of the carboxyl activating reagent and the reducing reagent used is 1:1 to 5:1 to 10:1 to 10; and the reaction temperature is -20 to 120 ° C;
- the compound represented by Formula 1 is first subjected to reductive amination reaction with glyoxal dimethyl acetal in a reactor to obtain a compound represented by Formula 4, followed by Formula 4
- the compound shown is substituted with a thiol (R 8 SH and R 9 SH) under Lewis acid catalysis to produce a chiral spiro phosphine-nitrogen-sulfur tridentate ligand of formula II;
- the molar ratio of the compound shown to glyoxal dimethyl acetal, Lewis acid, thiol (R 8 SH and R 9 SH) is 1:1 to 5:0.1 to 5:1 to 10; the reaction temperature is - 10 to 120 ° C;
- the organic solvent may be methanol, ethanol, propanol, isopropanol, butanol, tetrahydrofuran, toluene, xylene, methyl tert-butyl ether, diethyl ether, dioxane, N, a mixed solvent of one or a combination of N-dimethylformamide, dimethyl sulfoxide, dichloromethane, chloroform, 1,2-dichloroethane;
- the reducing agent may be lithium aluminum hydride, Sodium borohydride, sodium triacetoxyborohydride, sodium nitrile borohydride;
- the base comprises an organic base and an inorganic base, wherein the organic base may be pyridine, triethylamine, tributylamine, N-methylmorpholine , N,N-diethylisopropylamine;
- the inorganic base may be sodium hydroxide, potassium hydroxide, sodium carbonate or potassium carbonate;
- the use of the chiral spiro phosphine-nitrogen-sulfur tridentate ligand of the present invention is for catalyzing the asymmetric catalytic hydrogenation of carbonyl compounds such as ⁇ -ketoester, ⁇ -ketoamide and simple ketone.
- the chiral spirophosphinyl-nitro-sulfur tridentate ligand is first formed into a complex with a transition metal salt, and then used to catalyze a carbonyl compound such as a ⁇ -ketoester, a ⁇ -ketoamide, and a simple ketone.
- a carbonyl compound such as a ⁇ -ketoester, a ⁇ -ketoamide, and a simple ketone.
- the chiral spirophosphinyl-nitro-sulfur tridentate ligand and the transition metal salt are added to an organic solvent under an inert gas atmosphere, and reacted at a reaction condition of 25 to 120 ° C for 0.5 to 4 hours. Then, the reaction is stirred for 0.1 to 3 hours in a hydrogen atmosphere of 0.1 to 50 atm to prepare a complex of a chiral spiro phosphine-nitrogen-sulfur tridentate ligand and a transition metal salt.
- the molar ratio of the chiral spiro phosphine-nitrogen-sulfur tridentate ligand to the transition metal salt is 1:1 to 2:1, and the ratio is preferably 1.5:1 to 2:1. .
- the transition metal salt is a metal salt of cerium.
- the organic solvent is methanol, ethanol, propanol, isopropanol, butanol, tetrahydrofuran, toluene, methyl tert-butyl ether, dioxane, N,N-dimethylformamide , one or a mixed solvent of dimethyl sulfoxide.
- a carbonyl compound and a base are added to the solution solution obtained by the preparation, and a hydrogenation reaction is carried out under a hydrogen atmosphere of 0.1 to 100 atm and 0 to 80 ° C; the carbonyl compound and the mole of the complex The ratio is 100:1 to 500000:1.
- the substrate concentration is 0.001 to 10.0 M, and the alkali concentration is 0.005 ⁇ to 1.0 ⁇ ; the alkali is sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, sodium ethoxide, potassium ethoxide, sodium t-butoxide, and tert-butyl Potassium alkoxide, lithium t-butoxide, triethylamine, tributylamine or N-methylmorpholine.
- the chiral spirophosphinyl-nitro-sulfur tridentate ligand is selected from the following compounds or enantiomers, racemates or catalytically acceptable salts thereof;
- the chiral spiro phosphine-nitrogen-sulfur tridentate ligand provided by the invention has the main structural features of a chiral spiroindoline skeleton and a thioether group, which can be used as a chiral ligand for rhodium catalyzed carbonyl compounds.
- asymmetric catalytic hydrogenation reaction a very high yield is obtained in the asymmetric hydrogenation of carbonyl compounds including arylalkyl ketones, alkenones, ⁇ -ketoesters and ⁇ -ketoamides. (>90%) and enantioselectivity (up to 99.9% ee).
- the activity of the reaction is also very high, and the number of conversions can be as high as 350,000. Compared with the prior art, the present invention has the following remarkable effects:
- the chiral spiro phosphine-nitrogen-sulfur tridentate ligand provided by the present invention forms a complex with a transition metal salt, and has high catalytic activity and enantioselectivity for asymmetric hydrogenation of a carbonyl compound such as a keto ester.
- asymmetric hydrogenation of a carbonyl compound such as a keto ester.
- the highest number of conversions to date is given in the asymmetric hydrogenation of ⁇ -alkyl- ⁇ -ketoesters.
- the preparation method of the chiral spiro phosphine-nitrogen-sulfur tridentate ligand provided by the invention is simple, and is particularly suitable for The asymmetric catalytic hydrogenation of carbonyl compounds has mild reaction conditions, high efficiency, and is suitable for large-scale production, and has practical value.
- anhydrous aluminum chloride 120 mg, 0.9 mmol
- lithium aluminum hydride 34 mg, 0.9 mmol
- 3 mL of anhydrous diethyl ether 3 mL
- the reaction was allowed to cool to room temperature after 0.5 hours.
- the reaction was quenched by dropwise addition of 2 mL of water to the mixture, and the mixture was separated, and the aqueous phase was extracted with ethyl acetate (3mL ⁇ 3).
- the organic phase was washed with brine, dried over anhydrous magnesium sulfate and dried.
- the desiccant was removed by suction filtration, and the filtrate was removed by a rotary evaporator. The residue was subjected to EtOAcjjjjjjli
- the reaction system was filtered through Celite to remove palladium carbon, and the solvent was evaporated to dryness.
- the desiccant was removed by suction filtration, and the filtrate was subjected to removal of the solvent by a rotary evaporator, and the crude product was directly used for the next substitution reaction.
- the mixture was cooled to room temperature, and the mixture was evaporated, evaporated, evaporated, evaporated
- the desiccant was removed by suction filtration, and the crude product obtained by desolvation with a rotary evaporator was directly used for the next substitution reaction.
- Ligand (R)-I or II (1.65 ⁇ mol) and [Ir(COD)Cl] 2 (0.5 mg, 0.75 ⁇ mol) were weighed into a dry, clean 10 mL Schlenk tube equipped with a magnetic stir bar in a glove box. Sealed for use. After taking out, 1 mL of anhydrous methanol was added, and the mixture was stirred at room temperature for 0.5 hour.
- the solution was added to a hydrogenation reactor equipped with a glass inner tube and a magnetic stirrer with a syringe, and the gas in the reaction vessel was rapidly replaced with hydrogen three times to adjust the hydrogen pressure to 10 atm (ligand (R)- II, at this time, the hydrogen pressure was adjusted to 30 atm), and after stirring at room temperature for 0.5 hour, the hydrogen in the reaction vessel was slowly released.
- a hydrogenation reactor equipped with a glass inner tube and a magnetic stirrer with a syringe
- the gas in the reaction vessel was rapidly replaced with hydrogen three times to adjust the hydrogen pressure to 10 atm (ligand (R)- II, at this time, the hydrogen pressure was adjusted to 30 atm), and after stirring at room temperature for 0.5 hour, the hydrogen in the reaction vessel was slowly released.
- 7.5-150 mmol of substrate solid substrate dissolved in methanol
- 0.05-25 mmol of sodium hydroxide in methanol 0.5 mL (0.1 mmol/mL) ⁇ 25 mL (
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
Description
Claims (19)
- 一种手性螺环膦-氮-硫三齿配体,是具有通式I或通式II的化合物或所述化合物的对映体、消旋体,或其催化可接受的盐。其中,R1选自C1~C10的烃基、苯基、取代苯基、1-萘基、2-萘基、杂芳基或苄基,所述的苯基上的取代基为C1~C10的烃基、烷氧基,取代基数量为1~5,杂芳基为呋喃基、噻吩基或吡啶基;R2、R3、R4、R5分别独立选自H、C1~C10烷基、苯基、取代苯基、1-萘基、2-萘基、杂芳基或苄基,所述的苯基上的取代基为C1~C10的烃基、烷氧基,取代基数量为1~5,杂芳基为呋喃基、噻吩基或吡啶基;或C1~C10烷氧基;或R2~R3、R4~R5并为C3~C7脂肪环、芳香环;R2、R3、R4、R5可以相同也可以不同;R6、R7分别独立选自H、C1~C10烷基、C1~C10烷氧基、C1~C10脂肪胺基,n=0~3;或当n≥2时,两个相邻的R6、R7可并为C3~C7脂肪环或芳香环,R6、R7可以相同也可以不同;R8、R9分别独立选自C1~C10烷基、C1~C10烷氧基,苯基、取代苯基、1-萘基、2-萘基、杂芳基或苄基,所述的苯基上的取代基为C1~C10的烃基、烷氧基,取代基数量为1~5,杂芳基为呋喃基、噻吩基或吡啶基;或R8和R9可通过C2~C4的碳链,含氮、氧、硫的碳链、芳香环、或杂芳香环连接成环;R8、R9可以相同也可以不同。
- 根据权利要求1或2所述的手性螺环膦-氮-硫三齿配体的合成方法,其特征,包括如下步骤:在有机溶剂和碱存在的条件下,具有式1所示的化合物先与式2所示的化合物(X不为H和OH)在反应器中反应2~24小时制备得到式3所示的化合物;式3所示的化合物随后经还原试剂还原得到式I所示的手性螺环膦-氮-硫三齿配体;或在有机溶剂和还原试剂存在的条件下具有式1所示的化合物先与式2所示的化合物(X为H)在反应器中反应2~24小时直接制备得到式I所示的手性螺环膦-氮-硫三齿配体。
- 根据权利要求4所述的合成方法,其特征在于,所述式1所示的化合物与式2所示的化合物以及使用的还原试剂的摩尔比为1:1~5:1~10;反应温度为-20~120℃。
- 根据权利要求1或2所述的手性螺环膦-氮-硫三齿配体的合成方法,其特征,包括如下步骤:在有机溶剂、碱和羧基活化试剂存在的条件下,具有式1所示的化合物先与式2所示的化合物(X为OH)在反应器中反应2~24小时制备得到式3所示的化合物;式3所示的化合物随后经还原试剂还原得到式I所示的手性螺环膦-氮-硫三齿配体。
- 根据权利要求6所述的合成方法,其特征在于,所述式1所示的化合物与式2所示的化合物(X为OH)以及使用的羧基活化试剂、还原试剂的摩尔比为1:1~5:1~10:1~10;反应温度为-20~120℃。
- 根据权利要求1或3所述的手性螺环膦-氮-硫三齿配体的合成方法,其特征,包括如下步骤:在有机溶剂和还原试剂存在的条件下,具有式1所示的化合物先与乙二醛二甲基缩醛在反应器中发生还原胺化反应制得式4所示的化合物,随后式4所示的化合物与硫醇(R8SH和R9SH)在路易斯酸催化下发生置换反应制得式II所示的手性螺环膦-氮-硫三齿配体。
- 根据权利要求8所述的合成方法,其特征在于,所述具有式1所示的化合物与乙二醛二甲基缩醛、路易斯酸、硫醇(R8SH和R9SH)的摩尔比为1:1~5:0.1~5:1~10;;反应温度为-10~120℃。
- 根据权利要求4、6或8所述的合成方法,其特征在于,所述有机溶剂为甲醇、乙醇、丙醇、异丙醇、丁醇、四氢呋喃、甲苯、二甲苯、甲基叔丁基醚、乙醚、二氧六环、N,N-二甲基甲酰胺、二甲亚砜、二氯甲烷、氯仿、1,2-二氯乙烷中的一种或其中几种的混合溶剂;所述还原试剂为氢化铝锂、硼氢化钠、三乙酰氧基硼氢化钠、腈基硼氢化钠;所述的碱包括有机碱和无机碱,其中有机碱为吡啶、三乙胺、三丁胺、N-甲基吗啡啉、N,N-二乙基异丙基胺;无机碱为氢氧化钠、氢氧化钾、碳酸钠、碳酸钾;所述的羧基活化试剂为氯甲酸乙酯、氯甲酸异丙酯、N,N′-二环己基碳二亚胺、羰基二咪唑;所述的路易斯酸为四氯化钛、三氟化硼、三氯化铟、四氯化锆、四氯化碲、硅钨酸、硫酸铜。
- 权利要求1中所述的手性螺环膦-氮-硫三齿配体,其对映体、消旋体、或其催化可接受的盐的应用,其特征在于,用于催化β-酮酸酯、β-酮酰胺和简单酮等羰基化合物的不对称催化氢化反应。
- 权利要求11中所述的手性螺环膦-氮-硫三齿配体,其对映体、消旋体、 或其催化可接受的盐的应用,其特征在于,首先将所述的手性螺环膦-氮-硫三齿配体与过渡金属盐形成配合物,然后用于催化β-酮酸酯、β-酮酰胺和简单酮等羰基化合物的不对称催化氢化反应。
- 一种权利要求12中所述的手性螺环膦-氮-硫三齿配体,其对映体、消旋体或其催化可接受的盐形成的配合物的制备方法,其特征在于,包括如下步骤:在有机溶剂和25~120℃的反应条件下,手性螺环膦-氮-硫三齿配体首先与铱催 化剂前体反应0.5~4小时,然后再在0.1~50atm的氢气氛围中搅拌反应0.1~3小时便可得到氢化反应所需的手性催化剂;所述的手性螺环胺基膦配体与铱催化剂的摩尔比为1:1~2:1;所述的铱催化剂前体为[Ir(COD)Cl]2(COD=环辛二烯)、[Ir(COD)2]BF4、[Ir(COD)2]PF6、[Ir(COD)2]SbF6或[Ir(COD)2]OTf。
- 根据权利要求12所述的手性螺环膦-氮-硫三齿配体,其对映体、消旋体或其催化可接受的盐形成的配合物的应用,其特征在于,可直接不脱溶或脱溶后制备成可存放的固体用于催化β-酮酸酯、β-酮酰胺和简单酮等羰基化合物的不对称催化氢化反应。
- 一种手性醇类化合物的制备方法,其特征在于,在有机溶剂中,以权利要求12中所制备的配合物为手性催化剂,加入羰基化合物和碱,并在0.1~100atm的氢气氛围中搅拌反应0.1~80小时得到手性醇类化合物。
- 根据权利要求17中所述的手性醇类化合物的制备方法,其特征是羰基底物与催化剂的摩尔比为100:1~500000:1(即催化剂用量为1~0.0002mol%);底物浓度为0.001~10.0M;碱为氢氧化钠、氢氧化钾、碳酸钠、碳酸钾、乙醇钠、乙醇钾、叔丁醇钠、叔丁醇钾、叔丁醇锂、三乙胺、三丁胺或N-甲基吗啉;碱浓度为0.005Μ~1.0Μ;反应温度为0~80℃。
- 根据权利要求15或17所述的制备方法,其特征在于,所述的有机溶剂为甲醇、乙醇、丙醇、异丙醇、丁醇、四氢呋喃、甲苯、甲基叔丁基醚、二氧六环、N,N-二甲基甲酰胺、二甲亚砜中的一种或其中几种的混合溶剂。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/572,160 US10550138B2 (en) | 2015-05-15 | 2016-01-16 | Chiral spiro phosphorus-nirogen-sulphur tridentate ligand, preparation method and application thereof |
EP16795647.3A EP3296302B1 (en) | 2015-05-15 | 2016-01-26 | Chiral spiro phosphorus-nitrogen-sulphur tridentate ligand, and preparation method and application thereof |
JP2017558681A JP6910960B2 (ja) | 2015-05-15 | 2016-01-26 | カイラルスピロ環ホスフィン−窒素−硫黄三座配位子およびその調製方法と応用 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510246052.1 | 2015-05-15 | ||
CN201510246052.1A CN104892672B (zh) | 2015-05-15 | 2015-05-15 | 手性螺环膦-氮-硫三齿配体及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2016184160A1 true WO2016184160A1 (zh) | 2016-11-24 |
Family
ID=54025682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2016/072087 WO2016184160A1 (zh) | 2015-05-15 | 2016-01-26 | 手性螺环膦-氮-硫三齿配体及其制备方法和应用 |
Country Status (5)
Country | Link |
---|---|
US (1) | US10550138B2 (zh) |
EP (1) | EP3296302B1 (zh) |
JP (1) | JP6910960B2 (zh) |
CN (1) | CN104892672B (zh) |
WO (1) | WO2016184160A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112812097A (zh) * | 2021-01-26 | 2021-05-18 | 河南师范大学 | 可见光催化合成3-(2-吡啶)取代吡咯类化合物的方法 |
WO2023077643A1 (zh) * | 2021-11-03 | 2023-05-11 | 凯特立斯(深圳)科技有限公司 | 一种手性多齿配体及其在不对称氢化的应用 |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9950282B2 (en) | 2012-03-15 | 2018-04-24 | Flodesign Sonics, Inc. | Electronic configuration and control for acoustic standing wave generation |
US10704021B2 (en) | 2012-03-15 | 2020-07-07 | Flodesign Sonics, Inc. | Acoustic perfusion devices |
US10967298B2 (en) | 2012-03-15 | 2021-04-06 | Flodesign Sonics, Inc. | Driver and control for variable impedence load |
US9458450B2 (en) | 2012-03-15 | 2016-10-04 | Flodesign Sonics, Inc. | Acoustophoretic separation technology using multi-dimensional standing waves |
WO2015105955A1 (en) | 2014-01-08 | 2015-07-16 | Flodesign Sonics, Inc. | Acoustophoresis device with dual acoustophoretic chamber |
US11708572B2 (en) | 2015-04-29 | 2023-07-25 | Flodesign Sonics, Inc. | Acoustic cell separation techniques and processes |
US11021699B2 (en) | 2015-04-29 | 2021-06-01 | FioDesign Sonics, Inc. | Separation using angled acoustic waves |
US11377651B2 (en) | 2016-10-19 | 2022-07-05 | Flodesign Sonics, Inc. | Cell therapy processes utilizing acoustophoresis |
CN104892672B (zh) * | 2015-05-15 | 2018-09-21 | 浙江九洲药业股份有限公司 | 手性螺环膦-氮-硫三齿配体及其制备方法和应用 |
US11474085B2 (en) | 2015-07-28 | 2022-10-18 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
US11459540B2 (en) | 2015-07-28 | 2022-10-04 | Flodesign Sonics, Inc. | Expanded bed affinity selection |
US11214789B2 (en) | 2016-05-03 | 2022-01-04 | Flodesign Sonics, Inc. | Concentration and washing of particles with acoustics |
US11085035B2 (en) | 2016-05-03 | 2021-08-10 | Flodesign Sonics, Inc. | Therapeutic cell washing, concentration, and separation utilizing acoustophoresis |
CN110494543A (zh) | 2016-10-19 | 2019-11-22 | 弗洛设计声能学公司 | 通过声学的亲和细胞提取 |
CN106518931B (zh) * | 2016-10-27 | 2021-08-24 | 南开大学 | 一种新型螺环膦-羧酸的铱络合物及其制备方法和应用 |
JP2021507561A (ja) | 2017-12-14 | 2021-02-22 | フロデザイン ソニックス, インク.Flodesign Sonics, Inc. | 音響トランスデューサドライバ及びコントローラ |
CN109956970A (zh) * | 2017-12-26 | 2019-07-02 | 南开大学 | 联苯型三齿配体钌络合物及其制备方法和应用 |
CN110128472B (zh) * | 2018-02-08 | 2021-04-02 | 凯特立斯(深圳)科技有限公司 | 一种氧杂螺环pnn类型配体的合成与应用 |
CN109666044B (zh) * | 2018-07-04 | 2021-03-05 | 浙江大学 | 基于[2.2]对环芳烷骨架的有机磷化合物及其中间体和制备方法与用途 |
CN110790708B (zh) * | 2018-08-02 | 2022-10-11 | 浙江九洲药业股份有限公司 | 一种艾利西平中间体的制备方法 |
CN109928995A (zh) * | 2019-04-08 | 2019-06-25 | 南开大学 | 手性螺环膦-氨基-噁唑啉三齿配体及其制备方法和应用 |
CN111484533B (zh) * | 2020-01-09 | 2022-05-06 | 浙江九洲药业股份有限公司 | 手性螺环膦-氮-膦三齿配体及其铱催化剂的制备方法和应用 |
CN111718353B (zh) * | 2020-08-04 | 2023-02-10 | 许昌恒生制药有限公司 | 一种磷酸西格列汀的制备方法 |
CN113105643A (zh) * | 2021-04-02 | 2021-07-13 | 山东师范大学 | 二维手性Organometallics Framework的制备及其应用 |
CN113354552B (zh) * | 2021-06-30 | 2023-04-11 | 合肥工业大学 | 一种v型有机配体的合成方法、合成的v型有机配体及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101671365A (zh) * | 2009-09-18 | 2010-03-17 | 南开大学 | 手性螺环胺基膦配体化合物与合成方法及其应用 |
CN102040625A (zh) * | 2010-11-19 | 2011-05-04 | 南开大学 | 手性螺环吡啶胺基膦配体化合物与合成方法及其应用 |
CN104892672A (zh) * | 2015-05-15 | 2015-09-09 | 南开大学 | 手性螺环膦-氮-硫三齿配体及其制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101058532A (zh) * | 2006-11-28 | 2007-10-24 | 南开大学 | 羟基的邻位具有手性中心的手性伯醇和仲醇的制备方法及其应用 |
CN102391306B (zh) * | 2011-08-31 | 2014-09-03 | 浙江九洲药业股份有限公司 | 螺环苄胺-膦和制备方法及其应用 |
-
2015
- 2015-05-15 CN CN201510246052.1A patent/CN104892672B/zh active Active
-
2016
- 2016-01-16 US US15/572,160 patent/US10550138B2/en active Active
- 2016-01-26 JP JP2017558681A patent/JP6910960B2/ja active Active
- 2016-01-26 WO PCT/CN2016/072087 patent/WO2016184160A1/zh active Application Filing
- 2016-01-26 EP EP16795647.3A patent/EP3296302B1/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101671365A (zh) * | 2009-09-18 | 2010-03-17 | 南开大学 | 手性螺环胺基膦配体化合物与合成方法及其应用 |
CN102040625A (zh) * | 2010-11-19 | 2011-05-04 | 南开大学 | 手性螺环吡啶胺基膦配体化合物与合成方法及其应用 |
CN104892672A (zh) * | 2015-05-15 | 2015-09-09 | 南开大学 | 手性螺环膦-氮-硫三齿配体及其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
DENG-HUI BAO ET AL.: "Development of chiral spiro P-N-S ligands for iridium-catalyzed asymmetric hydrogenation of [3-alkyl-beta-ketoesters.", ANGEW. CHEM. INT. ED., vol. 54, 8 June 2015 (2015-06-08), pages 8791 - 8794, XP055330065 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112812097A (zh) * | 2021-01-26 | 2021-05-18 | 河南师范大学 | 可见光催化合成3-(2-吡啶)取代吡咯类化合物的方法 |
CN112812097B (zh) * | 2021-01-26 | 2023-01-13 | 河南师范大学 | 可见光催化合成3-(2-吡啶)取代吡咯类化合物的方法 |
WO2023077643A1 (zh) * | 2021-11-03 | 2023-05-11 | 凯特立斯(深圳)科技有限公司 | 一种手性多齿配体及其在不对称氢化的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104892672A (zh) | 2015-09-09 |
US10550138B2 (en) | 2020-02-04 |
EP3296302A1 (en) | 2018-03-21 |
US20180141966A1 (en) | 2018-05-24 |
EP3296302A4 (en) | 2018-10-24 |
CN104892672B (zh) | 2018-09-21 |
JP2018515515A (ja) | 2018-06-14 |
EP3296302B1 (en) | 2020-02-12 |
JP6910960B2 (ja) | 2021-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2016184160A1 (zh) | 手性螺环膦-氮-硫三齿配体及其制备方法和应用 | |
JP5923105B2 (ja) | キラルスピロ−ピリジルアミドフォスフィン配位子化合物、その合成方法及びその利用 | |
CN110724164B (zh) | 吡啶环上3-位取代手性螺环胺基膦配体制备方法及其应用 | |
WO2016082583A1 (zh) | 消旋δ-羟基酯的不对称催化氢化动力学拆分及其应用 | |
Erb et al. | Functionalization of 3-Iodo-N, N-Diisopropylferrocene-Carboxamide, a Pivotal Substrate to Open the Chemical Space to 1, 3-Disubstituted Ferrocenes | |
CN109970795A (zh) | 吡啶环上4-位取代手性螺环胺基膦配体制备方法及其应用 | |
CN111925356B (zh) | 手性喹啉-咪唑啉配体的合成方法及其应用 | |
JP5918386B2 (ja) | キラル触媒およびそれらの塩の製造方法 | |
CN109928995A (zh) | 手性螺环膦-氨基-噁唑啉三齿配体及其制备方法和应用 | |
CA3186051A1 (en) | Method for producing optically active compound | |
JP2015505827A5 (zh) | ||
EP3498684B1 (en) | Enantiopure terphenyls with two ortho-atropisomeric axes | |
CN112851470B (zh) | 一种合成手性二级醇化合物的方法 | |
CN114262308B (zh) | 一类2-亚甲基-2,3-二氢噻唑类化合物及其合成方法和应用 | |
CN1356333A (zh) | 新型非c2对称轴手性双膦配体、合成方法及其用途 | |
KR101654787B1 (ko) | 팔라듐 케토이미네이트 착화합물을 함유하는 촉매 조성물 및 이를 이용한 크로스커플링 화합물의 제조 방법 | |
JP5346434B2 (ja) | β,β―ビスへテロ置換光学活性アルコールの製造方法 | |
CA2413713A1 (en) | Novel resins bearing a chiral auxiliary for the construction of small chiral organic molecules | |
Dorcet et al. | Functionalization of 3-Iodo-N, N-diisopropylferrocene-carboxamide, a Pivotal Substrate to Open the Chemical Space to 1, 3-Disubstituted Ferrocenes | |
Bešťák | Picolinamide Derivatives of N-Methyl Valine as New Possible Chiral Organocatalysts in the Enantioselective Reduction of Aromatic Ketimines with Trichlorosilane | |
JP2009215204A (ja) | 環状α−ヒドロキシ−α,β−不飽和ケトン化合物及びシクロペンテノン化合物の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 16795647 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 15572160 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2017558681 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2016795647 Country of ref document: EP |